Neuland Laboratories Limited (BOM:524558)
11,420
+249 (2.22%)
At close: Feb 20, 2025
Neuland Laboratories Revenue
Neuland Laboratories had revenue of 3.98B INR in the quarter ending December 31, 2024, with 1.32% growth. This brings the company's revenue in the last twelve months to 15.33B, down -3.00% year-over-year. In the fiscal year ending March 31, 2024, Neuland Laboratories had annual revenue of 15.59B with 30.81% growth.
Revenue (ttm)
15.33B
Revenue Growth
-3.00%
P/S Ratio
9.20
Revenue / Employee
9.33M
Employees
1,643
Market Cap
141.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 15.59B | 3.67B | 30.81% |
Mar 31, 2023 | 11.91B | 2.40B | 25.20% |
Mar 31, 2022 | 9.52B | 147.07M | 1.57% |
Mar 31, 2021 | 9.37B | 1.73B | 22.64% |
Mar 31, 2020 | 7.64B | 965.74M | 14.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
Tata Consultancy Services | 2,520.82B |
HDFC Bank | 2,702.59B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 1,755.26B |
Infosys | 1,635.60B |
State Bank of India | 3,409.52B |
Hindustan Unilever | 626.61B |
Neuland Laboratories News
- 12 days ago - Neuland Laboratories shares drop 6% as Q3 EBITDA falls 29% YoY - Business Upturn
- 13 days ago - Neuland Laboratories Q3 FY25 Results: Net Profit surges 24.9% YoY, Revenue flat at Rs 398.03 crore - Business Upturn
- 4 weeks ago - Neuland Labs shares surge 3% after Rs 342 crore capex plan approval - Business Upturn
- 4 weeks ago - Top stocks to watch in trade today: Tech Mahindra, JSW Group, Neuland Labs, Railtel, PNB Housing and more - Business Upturn
- 4 weeks ago - Neuland Labs board approves Rs 342 crore capital expenditure - Business Upturn
- 2 months ago - Mixed trends in November CDRMO exports, prefer Syngene and Neuland Labs over Divis Labs and Laurus Labs - Business Upturn
- 2 months ago - Neuland Labs exports surge threefold YoY in November, 43.1% MoM growth - Business Upturn
- 2 months ago - Neuland Labs shares down over 5% as 4.8 lakh shares worth Rs 747 crore change hands in block trade - Business Upturn